| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| nilvadipine | voltage-dependent l-type calcium channel subunit alpha-1c | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris Variant[MeSHID:D000788] Stable angina[MeSHID:D060050] Disease Management[MeSHID:D019468] |
NA | approved,investigational | inhibitor |
| nilvadipine | voltage-dependent l-type calcium channel subunit alpha-1d | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris Variant[MeSHID:D000788] Stable angina[MeSHID:D060050] Disease Management[MeSHID:D019468] |
NA | approved,investigational | inhibitor |
| nilvadipine | voltage-dependent l-type calcium channel subunit alpha-1s | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris Variant[MeSHID:D000788] Stable angina[MeSHID:D060050] Disease Management[MeSHID:D019468] |
NA | approved,investigational | inhibitor |
| nilvadipine | voltage-dependent calcium channel subunit alpha-2/delta-1 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris Variant[MeSHID:D000788] Stable angina[MeSHID:D060050] Disease Management[MeSHID:D019468] |
NA | approved,investigational | inhibitor |
| nilvadipine | voltage-dependent calcium channel subunit alpha-2/delta-3 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris Variant[MeSHID:D000788] Stable angina[MeSHID:D060050] Disease Management[MeSHID:D019468] |
NA | approved,investigational | inhibitor |
| nilvadipine | voltage-dependent l-type calcium channel subunit beta-2 | small molecule | NA | drugbank | Hypertensive disease[MeSHID:D006973] Angina Pectoris Variant[MeSHID:D000788] Stable angina[MeSHID:D060050] Disease Management[MeSHID:D019468] |
NA | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||